The Quantellect read.As of Nov 19, 2026, 7 active firms cover Franklin Templeton Inc: 3 rate it Buy or better, 3 sit at Neutral, and 1 rate it Sell or worse, a neutral consensus. Targets are tightly clustered, $34.00 to $40.00, so the covering firms are broadly aligned. The average target of $35.86 sits 4% above the current $34.44. Sentiment has drifted a little more constructive lately, with Sell ratings easing from 2 to 1 over recent months. On the fundamentals, the Street sees revenue growth near 4% this year and 1% next, consensus EPS building from about $0.79 next quarter toward $3.64 the year after.Descriptive synthesis of third-party analyst data, not a Quantellect rating or recommendation.
ANALYST CONSENSUS7 active firms
Neutral
Strong Buy00%
Buy343%
Neutral343%
Sell114%
Strong Sell00%
Based on 7 active firms as of Nov 19, 2026 (365-day activity window).
12-MONTH PRICE TARGET
$35.86
+4.1% upside
Average target across 7 active firms as of Nov 19, 2026 vs $34.44 current
Highest Target$40.00
Average Target$35.86
Lowest Target$34.00
Detailed analyst forecasts for BEN
Showing 1–8 of 8 named analysts shown · 7 active firms in the rating projection
As of Nov 19, 2026, 3 of 7 active firms rate BEN a Buy (3 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
BEN EPS & revenue forecast
EPS · NEXT QUARTER
$0.79
Range $0.74 – $0.89 · 10 analysts · +11% YoY
Next period, 10 analysts expect Franklin Templeton Inc. to earn $0.79 a share (range $0.74 – $0.89), versus $0.71 a year earlier. Full-year consensus is $3.23, growing to $3.64 the year after.
REVENUE · NEXT QUARTER
$2.2B
Range $1.9B – $2.5B · 10 analysts · +2% YoY
Revenue is expected to reach $2.2B (range $1.9B – $2.5B), +2.0% year-over-year. Full-year consensus is $9.2B, rising to $9.6B next year.
Top analysts covering Franklin Templeton Inc.
Ranked by each analyst's overall Quantellect track record across all the stocks they cover, shown with their current call on BEN.
#1
Alexander Blostein
Goldman Sachs · Rank #52
Buy
$40.00+16.2% to target
Overall win rate
56%
+ Follow
#2
Benjamin Budish
Barclays · Rank #180
Neutral
$36.00+4.5% to target
Overall win rate
44%
+ Follow
#3
MB
Michael Brown
Wells Fargo · Rank #335
Neutral
$26.00-24.5% to target
Overall win rate
35%
+ Follow
#4
Michael Cyprys
Morgan Stanley · Rank #358
Neutral
$35.00+1.6% to target
Overall win rate
38%
+ Follow
#5
David Motemaden
Evercore ISI Group
Sell
$35.00+1.6% to target
Coverage
—
+ Follow
BEN stock forecast FAQ
What is BEN's average 12-month price target?+
The 7 active firms with a live target average $35.86 for Franklin Templeton Inc. over the next 12 months, ranging from a $40.00 high to a $34.00 low, as of Nov 19, 2026.
Is BEN stock a Buy, Sell or Neutral right now?+
The current consensus is Neutral. Of the 7 active firms as of Nov 19, 2026, 3 rate it Buy or Strong Buy, 3 rate it Neutral, and 1 rate it Sell or Strong Sell.
What are the highest and lowest price targets for BEN?+
The Street-high target is $40.00 (UBS), and the Street-low is $34.00 (Barclays). The average of all 7 active-firm targets is $35.86.
How many active Wall Street firms cover BEN?+
7 active firms have a recognized rating on Franklin Templeton Inc. as of Nov 19, 2026, and 7 active firms carry a live 12-month price target.
Who is the most accurate analyst covering BEN?+
Among analysts who currently cover BEN, Alexander Blostein of Goldman Sachs has the strongest overall Quantellect track record (Rank #52). Their current call is Buy with a $40.00 target.
What is Franklin Templeton Inc.'s projected EPS for next quarter?+
The consensus estimate is $0.79 per share (range $0.74 – $0.89) across 10 analysts. Full-year EPS is projected at $3.23, rising to $3.64 the following year.
How much revenue is Franklin Templeton Inc. expected to report next quarter?+
Consensus revenue is $2.2B (range $1.9B – $2.5B). Full-year revenue is projected at $9.2B, growing to $9.6B next year.
Have analysts been upgrading or downgrading BEN lately?+
As of Nov 19, 2026, 3 of 7 active firms rate BEN a Buy (3 Neutral, 1 Sell). Historical months are month-end active-firm counts; the current month uses its actual as-of date.
How are the analysts on this page ranked?+
By each analyst's overall Quantellect track record — a sample-adjusted measure of how accurate their calls have been across every stock they cover. We do not rank on their BEN calls alone, since a single stock is too small a sample to be reliable.
Which data on this page is live, and how often does it update?+
Price and daily change are 15-minute delayed market data. Analyst ratings, targets, consensus and earnings estimates are aggregated from multiple data providers and refresh daily.
Disclaimer: Ratings, price targets, consensus and earnings estimates on this page describe third-party analyst research aggregated from multiple data providers and refreshed daily; price and daily change are 15-minute delayed. These are historical opinions, not recommendations, and nothing on this page, including The Quantellect read, is a rating, a price target, or investment advice from Quantellect. Always do your own research and consult a licensed financial advisor before making investment decisions.